KLK14 and ovarian cancer: Significantly better response to platinum-based chemotherapy was seen in patients with KLK14-positive ovarian cancer [67 of 70 (95.7%)], compared to those with KLK14-negative tumor [58 of 72 (77.3%)] [92].